VintaBio
PrivateLast Round
Early Funding
Apr 11, 2023
Total Funding Raised
$64M
Company Overview
VintaBio operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. Its latest recorded funding round was an Early Funding round in April 2023.
VintaBio is a biotechnology company that provides contract development and manufacturing services for viral vectors used in cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VintaBio Comparables
Compare VintaBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ascend | 90% | |
| Advanced Medicine Partners | 89% | |
| Vector BioMed, Inc. | 89% |
For institutional investors. Book with your work email.
VintaBio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VintaBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GE UK Group | Early Funding |
| Decheng Capital | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2025
Presented proprietary VintaProcess data at the ASGCT Annual Meeting.
- Jan 1, 2025
Announced VintaProcess™ for analytical and process optimization.
For institutional investors. Book with your work email.
VintaBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VintaBio's valuation, stock price, and market status.
Is VintaBio a public or private company?
VintaBio is a private company.
What is the current stock price of VintaBio?
VintaBio is a private company, so its shares have no public market price. Caplight tracks VintaBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VintaBio worth (valuation)?
Valuation information for VintaBio is not publicly available.
Can I buy VintaBio stock?
VintaBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VintaBio's last funding round?
VintaBio's most recent funding round was Early Funding on April 11, 2023.
Who are the main investors in VintaBio?
Key investors in VintaBio include Decheng Capital.
Will VintaBio IPO soon?
No public IPO plans have been announced for VintaBio.
How can I track VintaBio secondary market activity?
Caplight tracks bids, offers, and trades in VintaBio's shares on secondary markets.